FC
Finepoint Capital Portfolio holdings
AUM
$504M
This Quarter Return
+0.45%
1 Year Return
-3.16%
3 Year Return
+45.14%
5 Year Return
–
10 Year Return
–
AUM
$867M
AUM Growth
+$867M
(+5.4%)
Cap. Flow
+$56.6M
Cap. Flow
% of AUM
6.53%
Top 10 Holdings %
Top 10 Hldgs %
90.1%
Holding
31
New
5
Increased
10
Reduced
4
Closed
5
Top Buys
| 1 |
Liberty Live Group Series C
LLYVK
|
$55.3M |
| 2 |
Xencor
XNCR
|
$15.2M |
| 3 |
Avidity Biosciences
RNA
|
$11.4M |
| 4 |
SWTX
SpringWorks Therapeutics
SWTX
|
$3.54M |
| 5 |
Sarepta Therapeutics
SRPT
|
$3.45M |
Top Sells
| 1 |
Travere Therapeutics
TVTX
|
$24.9M |
| 2 |
Acadia Pharmaceuticals
ACAD
|
$13.9M |
| 3 |
QXO
QXO Inc
QXO
|
$13M |
| 4 |
Revolution Medicines
RVMD
|
$949K |
| 5 |
argenx
ARGX
|
$923K |
Sector Composition
| 1 | Industrials | 45.73% |
| 2 | Healthcare | 30.46% |
| 3 | Communication Services | 23.76% |
| 4 | Energy | 0.02% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
|
QXO
1
QXO Inc
QXO
$13.6B
| $396M | 24.21% | 24,933,825 -816,956 | -3% | -$13M |
|
2
Liberty Broadband Class C
LBRDK
$8.73B
| $151M | 9.2% | 2,015,710 +21,200 | +1% | +$1.58M |
|
|
3
Liberty Live Group Series C
LLYVK
$8.95B
| $55.3M | 3.38% | +812,792 | New | +$55.3M |
|
|
4
argenx
ARGX
$43.6B
| $32.6M | 1.99% | 52,928 -1,500 | -3% | -$923K |
|
|
5
Revolution Medicines
RVMD
$7.1B
| $31.1M | 1.9% | 710,260 -21,700 | -3% | -$949K |
|
|
SWTX
6
DELISTED
SpringWorks Therapeutics
SWTX
| $27.1M | 1.65% | 748,752 +97,900 | +15% | +$3.54M |
|
7
Ascendis Pharma
ASND
$11.8B
| $25.5M | 1.55% | 184,872 -5,200 | -3% | -$716K |
|
8
MoonLake Immunotherapeutics
MLTX
$3.54B
| $24.3M | 1.48% | 447,935 +59,100 | +15% | +$3.2M |
|
|
9
Sarepta Therapeutics
SRPT
$1.78B
| $19.7M | 1.2% | 161,935 +28,400 | +21% | +$3.45M |
|
10
Galapagos
GLPG
$2.07B
| $18.6M | 1.13% | 674,762 +117,000 | +21% | +$3.22M |
|
|
11
Xencor
XNCR
$580M
| $15.2M | 0.93% | +660,000 | New | +$15.2M |
|
12
Cytokinetics
CYTK
$4.23B
| $15M | 0.91% | 318,448 +61,999 | +24% | +$2.92M |
|
13
Arvinas
ARVN
$568M
| $13.7M | 0.84% | 713,778 +139,400 | +24% | +$2.67M |
|
|
14
Avidity Biosciences
RNA
$5.99B
| $11.4M | 0.69% | +391,300 | New | +$11.4M |
|
15
Prothena Corp
PRTA
$441M
| $9.1M | 0.56% | 657,071 +223,600 | +52% | +$3.1M |
|
16
Relay Therapeutics
RLAY
$619M
| $8.96M | 0.55% | 2,175,646 +549,500 | +34% | +$2.26M |
|
17
EyePoint Pharmaceuticals
EYPT
$797M
| $8.28M | 0.51% | 1,111,104 +403,700 | +57% | +$3.01M |
|
18
Solid Biosciences
SLDB
$427M
| $3.85M | 0.23% | 961,251 | – | – |
|
|
ANNA
19
AleAnna, Inc. Class A Common Stock
ANNA
$165M
| $197K | 0.01% | +27,717 | New | +$197K |
|
|
ANNAW
20
AleAnna, Inc. Warrant
ANNAW
$8.72M
| $68.6K | ﹤0.01% | +490,000 | New | +$68.6K |
|
|
MNYWW
21
MoneyHero Limited Warrants
MNYWW
$1.89M
| $49.4K | ﹤0.01% | 895,000 | – | – |
|
|
LSBPW
22
LakeShore Biopharma Co., Ltd Warrants
LSBPW
$3.51M
| $48.5K | ﹤0.01% | 489,999 | – | – |
|
|
GATEW
23
DELISTED
Marblegate Acquisition Corp. Warrant
GATEW
| $25.7K | ﹤0.01% | 735,000 | – | – |
|
24
Calidi Biotherapeutics
CLDI
$8.83M
| $14.4K | ﹤0.01% | 12,500 | – | – |
|
|
CDAQW
25
DELISTED
Compass Digital Acquisition Corp. Warrant
CDAQW
| – | – | -459,906 | Closed | -$28.1K |
|